US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nextcure Inc.

11.93

+3.2337.13%

Post-market: 11.82-0.1100-0.92%19:58 EDT

Volume:439.92K

Turnover:4.87M

Market Cap:31.93M

PE:-0.46

High:13.17

Open:8.60

Low:7.90

Close:8.70

52wk High:19.20

52wk Low:2.69

Shares:2.68M

Float Shares:2.06M

Volume Ratio:5.33

T/O Rate:21.36%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-25.9981

EPS(LYR):-23.8819

ROE:-105.88%

ROA:-53.12%

PB:1.08

PE(LYR):-0.50

Loading ...

Overview Company News Filings

NextCure Inc. Releases Corporate Presentation Highlighting Progress of Targeted Cancer Therapies and Ongoing Clinical Trials

BRIEF-NextCure And Simcere Zaiming Announce Expansion Of Ongoing Phase 1 Trial Of SIM0505 Into The US

NextCure and Simcere Zaiming Expand Phase 1 Trial of SIM0505 (CDH6 ADC) into U.S.; First American Patient Dosed

NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of Sim0505 (Cdh6 ADC) Into the United States

THOMSON REUTERS

NextCure Inc - Trial to Accelerate Proof-of-Concept Data in 1H 2026

THOMSON REUTERS

NextCure Inc. Unveils Latest Developments in Cancer Therapy Targeting and Clinical Trials Progress

NextCure Inc. Announces Resignation of Chief Scientific Officer Solomon Langermann, Effective September 1, 2025

NextCure Inc. Files Initial Statement of Beneficial Ownership for Simcere Zaiming, Inc

NextCure Inc reports results for the quarter ended June 30 - Earnings Summary

NextCure Q2 EPS $(11.29) Misses $(0.39) Estimate

NextCure Inc. Unveils Corporate Presentation Highlighting Licensing Agreement with Simcere and Progress in ADC Clinical Trials

NextCure Inc expected to post a loss of $4.61 a share - Earnings Preview

NextCure Shares Surge on Positive Data for Bone Treatment

NextCure Inc. Announces Promising Preclinical Results for Anti-Siglec-15 Treatment NC605 in Osteogenesis Imperfecta Model

U.S. RESEARCH ROUNDUP-Nvidia, Strategy, Targa Resources

NextCure Inc. Announces 1:12 Reverse Stock Split in Bylaw Amendment

NextCure Inc. Announces 1-for-12 Reverse Stock Split Effective July 14, 2025

NextCure Inc. Unveils Presentation on Licensing Agreement with Simcere Zaiming and Development Plans for Novel Therapeutic Candidates

NextCure Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

NextCure Inc. Conducted Annual Stockholders Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NXTC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NXTC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXTC\",,,,,undefined,":{"symbol":"NXTC","market":"US","secType":"STK","nameCN":"Nextcure Inc.","latestPrice":11.93,"timestamp":1760731200000,"preClose":8.7,"halted":0,"volume":439915,"hourTrading":{"tag":"盘后","latestPrice":11.82,"preClose":11.93,"latestTime":"19:58 EDT","volume":12501,"amount":146060.4115,"timestamp":1760745508375},"delay":0,"floatShares":2059900,"shares":2676110,"eps":-25.998072,"marketStatus":"Market Closed","change":3.23,"latestTime":"10-17 16:00:00 EDT","open":8.6,"high":13.17,"low":7.9,"amount":4873413.123285,"amplitude":0.605747,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-25.998072,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760947200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":8.7,"preHourTrading":{"tag":"盘前","latestPrice":8.6,"preClose":8.48,"latestTime":"09:27 EDT","volume":948,"amount":8094.1529279999995,"timestamp":1760707670158},"postHourTrading":{"tag":"盘后","latestPrice":11.82,"preClose":11.93,"latestTime":"19:58 EDT","volume":12501,"amount":146060.4115,"timestamp":1760745508375},"volumeRatio":5.3327296603109025,"impliedVol":0.7756,"impliedVolPercentile":0.3462},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXTC\",,,,,undefined,":{"symbol":"NXTC","floatShares":2059900,"roa":"-53.12%","roe":"-105.88%","lyrEps":-23.88188,"volumeRatio":5.3327296603109025,"shares":2676110,"dividePrice":0,"high":13.17,"amplitude":0.605747,"preClose":8.7,"low":7.9,"week52Low":2.688,"pbRate":"1.08","week52High":19.2,"institutionHeld":0,"latestPrice":11.93,"eps":-25.998072,"divideRate":0,"volume":439915,"delay":0,"ttmEps":-25.998072,"open":8.6,"prevYearClose":9.252,"prevWeekClose":6.65,"prevMonthClose":5.86,"prevQuarterClose":5.86,"fiveDayClose":6.65,"twentyDayClose":5.64,"sixtyDayClose":5.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NXTC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-07","symbol":"NXTC","fiscalQuarterEnding":"2025/06","expectedEps":-4.62,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-11.29},{"market":"US","date":"2025-07-14","symbol":"NXTC","defaultRemindTime":1752499800000,"type":"split","dateTimestamp":1752465600000,"forFactor":12,"toFactor":1,"ratio":12},{"market":"US","date":"2025-05-01","symbol":"NXTC","fiscalQuarterEnding":"2025/03","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746072000000,"reportTimeType":"post","actualEps":-0.39},{"market":"US","date":"2025-03-06","symbol":"NXTC","fiscalQuarterEnding":"2024/12","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-0.41},{"market":"US","date":"2024-11-07","symbol":"NXTC","fiscalQuarterEnding":"2024/09","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.41}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NXTC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NXTC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1752120000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NXTC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NXTC","date":"2025-10-16","current":-0.45888,"percent":0.885928,"low":-14.189621,"twenty":-3.075184,"median":-0.697724,"eighty":-0.489482,"high":-0.135872,"avg":-2.114982,"sd":2.872887,"marketCap":18224309},"quantilePoints":[{"date":"2020-10-23","current":-14.189621,"twenty":-41.27138,"median":-27.46669,"eighty":-14.322168,"marketCap":342480694},{"date":"2020-10-30","current":-11.027493,"twenty":-41.189991,"median":-27.128713,"eighty":-14.236598,"marketCap":266159574},{"date":"2020-11-06","current":-8.480121,"twenty":-41.167795,"median":-26.475836,"eighty":-13.976833,"marketCap":271948988},{"date":"2020-11-13","current":-9.064364,"twenty":-41.136349,"median":-26.354073,"eighty":-13.749015,"marketCap":290685088},{"date":"2020-11-20","current":-8.755059,"twenty":-40.514648,"median":-26.206102,"eighty":-13.641374,"marketCap":280765976},{"date":"2020-11-27","current":-8.918303,"twenty":-40.351822,"median":-26.067022,"eighty":-13.262672,"marketCap":286001063},{"date":"2020-12-04","current":-9.829035,"twenty":-40.327301,"median":-25.430624,"eighty":-13.109703,"marketCap":315207338},{"date":"2020-12-11","current":-10.009464,"twenty":-40.287319,"median":-25.13982,"eighty":-12.968149,"marketCap":320993486},{"date":"2020-12-18","current":-9.072956,"twenty":-40.246624,"median":-24.022963,"eighty":-12.529706,"marketCap":290960619},{"date":"2020-12-24","current":-9.227608,"twenty":-40.20593,"median":-23.053615,"eighty":-11.883665,"marketCap":295920175},{"date":"2020-12-31","current":-9.365077,"twenty":-40.154138,"median":-22.952466,"eighty":-11.632521,"marketCap":300328670},{"date":"2021-01-08","current":-9.725934,"twenty":-40.087547,"median":-22.868175,"eighty":-11.082288,"marketCap":311900967},{"date":"2021-01-15","current":-10.576523,"twenty":-40.022806,"median":-22.669256,"eighty":-10.920187,"marketCap":339178525},{"date":"2021-01-22","current":-11.684867,"twenty":-40.000609,"median":-22.606872,"eighty":-10.913337,"marketCap":374722010},{"date":"2021-01-29","current":-9.957913,"twenty":-39.883152,"median":-22.509937,"eighty":-10.825686,"marketCap":319340301},{"date":"2021-02-05","current":-10.838574,"twenty":-39.63991,"median":-22.278137,"eighty":-10.79991,"marketCap":347582217},{"date":"2021-02-12","current":-11.495847,"twenty":-39.538174,"median":-21.964329,"eighty":-10.816304,"marketCap":368660330},{"date":"2021-02-19","current":-11.46148,"twenty":-39.345801,"median":-21.898827,"eighty":-10.82087,"marketCap":367558207},{"date":"2021-02-26","current":-9.760301,"twenty":-39.260394,"median":-21.806107,"eighty":-10.758085,"marketCap":313003091},{"date":"2021-03-05","current":-8.528138,"twenty":-39.170898,"median":-21.646686,"eighty":-10.645232,"marketCap":312155423},{"date":"2021-03-12","current":-9.553625,"twenty":-38.728214,"median":-21.095397,"eighty":-10.591416,"marketCap":349691353},{"date":"2021-03-19","current":-8.995639,"twenty":-38.607359,"median":-20.947129,"eighty":-10.574805,"marketCap":329267391},{"date":"2021-03-26","current":-7.887208,"twenty":-38.189615,"median":-20.53714,"eighty":-10.497479,"marketCap":288695466},{"date":"2021-04-01","current":-7.600674,"twenty":-38.036186,"median":-20.431722,"eighty":-10.476459,"marketCap":278207485},{"date":"2021-04-09","current":-7.253818,"twenty":-37.964046,"median":-19.91028,"eighty":-10.436985,"marketCap":265511509},{"date":"2021-04-16","current":-7.103011,"twenty":-37.911895,"median":-19.800828,"eighty":-10.344839,"marketCap":259991519},{"date":"2021-04-23","current":-7.163334,"twenty":-37.74639,"median":-19.661526,"eighty":-10.243879,"marketCap":262199515},{"date":"2021-04-30","current":-6.615264,"twenty":-37.564472,"median":-19.472473,"eighty":-10.134144,"marketCap":242138498},{"date":"2021-05-07","current":-3.491362,"twenty":-37.360971,"median":-19.224757,"eighty":-10.031235,"marketCap":219498410},{"date":"2021-05-14","current":-3.574803,"twenty":-37.262304,"median":-18.761346,"eighty":-9.925264,"marketCap":224744284},{"date":"2021-05-21","current":-3.636286,"twenty":-37.225304,"median":-18.626168,"eighty":-9.822053,"marketCap":228609665},{"date":"2021-05-28","current":-3.447445,"twenty":-37.182137,"median":-18.248602,"eighty":-9.736327,"marketCap":216737424},{"date":"2021-06-04","current":-3.337654,"twenty":-37.110015,"median":-18.099377,"eighty":-9.595782,"marketCap":209834958},{"date":"2021-06-11","current":-3.530886,"twenty":-36.851954,"median":-17.442639,"eighty":-9.50942,"marketCap":221983298},{"date":"2021-06-18","current":-3.447445,"twenty":-36.561471,"median":-16.639291,"eighty":-9.440553,"marketCap":216737424},{"date":"2021-06-25","current":-3.724119,"twenty":-36.369847,"median":-16.350032,"eighty":-9.382261,"marketCap":234131638},{"date":"2021-07-02","current":-3.508928,"twenty":-36.147059,"median":-16.127312,"eighty":-9.350036,"marketCap":220602805},{"date":"2021-07-09","current":-3.456228,"twenty":-36.097991,"median":-16.01354,"eighty":-9.322118,"marketCap":217289621},{"date":"2021-07-16","current":-3.175163,"twenty":-35.890223,"median":-15.776513,"eighty":-9.179494,"marketCap":199619309},{"date":"2021-07-23","current":-3.100505,"twenty":-35.291831,"median":-15.643778,"eighty":-9.071426,"marketCap":194925632},{"date":"2021-07-30","current":-3.043413,"twenty":-34.894035,"median":-15.108422,"eighty":-8.999074,"marketCap":191336350},{"date":"2021-08-06","current":-3.171159,"twenty":-34.11786,"median":-14.908005,"eighty":-8.92174,"marketCap":210400049},{"date":"2021-08-13","current":-3.000532,"twenty":-33.677665,"median":-14.743075,"eighty":-8.837891,"marketCap":199079311},{"date":"2021-08-20","current":-2.9173,"twenty":-33.374217,"median":-14.648264,"eighty":-8.700071,"marketCap":193557000},{"date":"2021-08-27","current":-3.087926,"twenty":-33.313366,"median":-14.54037,"eighty":-8.596004,"marketCap":204877738},{"date":"2021-09-03","current":-3.221098,"twenty":-33.275794,"median":-14.353002,"eighty":-8.480121,"marketCap":213713435},{"date":"2021-09-10","current":-3.008855,"twenty":-33.23598,"median":-14.322168,"eighty":-8.271766,"marketCap":199631542},{"date":"2021-09-17","current":-2.913138,"twenty":-33.053529,"median":-14.252792,"eighty":-7.645917,"marketCap":193280885},{"date":"2021-09-24","current":-2.933946,"twenty":-33.005428,"median":-14.202654,"eighty":-7.51019,"marketCap":194661462},{"date":"2021-10-01","current":-3.146189,"twenty":-32.890386,"median":-14.0755,"eighty":-7.344302,"marketCap":208743355},{"date":"2021-10-08","current":-3.171159,"twenty":-32.869789,"median":-13.861335,"eighty":-7.118092,"marketCap":210400049},{"date":"2021-10-15","current":-3.633099,"twenty":-32.860746,"median":-13.744915,"eighty":-6.974825,"marketCap":241048875},{"date":"2021-10-22","current":-3.441665,"twenty":-32.779509,"median":-13.705498,"eighty":-6.816478,"marketCap":228347559},{"date":"2021-10-29","current":-3.420856,"twenty":-32.730233,"median":-13.510535,"eighty":-6.034448,"marketCap":226966982},{"date":"2021-11-05","current":-3.502552,"twenty":-32.66811,"median":-13.207877,"eighty":-3.671419,"marketCap":237861814},{"date":"2021-11-12","current":-2.615727,"twenty":-32.637276,"median":-13.133676,"eighty":-3.636286,"marketCap":177636639},{"date":"2021-11-19","current":-2.359443,"twenty":-32.603797,"median":-13.002396,"eighty":-3.614328,"marketCap":160232116},{"date":"2021-11-26","current":-2.448939,"twenty":-32.599568,"median":-12.990981,"eighty":-3.604396,"marketCap":166309886},{"date":"2021-12-03","current":-2.326899,"twenty":-32.562341,"median":-12.814039,"eighty":-3.59237,"marketCap":158022018},{"date":"2021-12-10","current":-2.489619,"twenty":-32.440719,"median":-12.477277,"eighty":-3.574803,"marketCap":169072509},{"date":"2021-12-17","current":-2.379783,"twenty":-32.255361,"median":-11.921142,"eighty":-3.545774,"marketCap":161613427},{"date":"2021-12-23","current":-2.514027,"twenty":-32.089537,"median":-11.883665,"eighty":-3.530886,"marketCap":170730082},{"date":"2021-12-31","current":-2.440803,"twenty":-31.909182,"median":-11.769509,"eighty":-3.517711,"marketCap":165757362},{"date":"2022-01-07","current":-2.294355,"twenty":-31.794602,"median":-11.710643,"eighty":-3.506378,"marketCap":155811920},{"date":"2022-01-14","current":-2.310627,"twenty":-31.648466,"median":-11.598274,"eighty":-3.489605,"marketCap":156916969},{"date":"2022-01-21","current":-2.180451,"twenty":-31.463026,"median":-11.504439,"eighty":-3.473795,"marketCap":148076576},{"date":"2022-01-28","current":-2.184519,"twenty":-31.270312,"median":-11.461384,"eighty":-3.453593,"marketCap":148352838},{"date":"2022-02-04","current":-2.172315,"twenty":-31.190863,"median":-11.27246,"eighty":-3.443977,"marketCap":147524052},{"date":"2022-02-11","current":-2.086886,"twenty":-31.093821,"median":-11.17795,"eighty":-3.412312,"marketCap":141722544},{"date":"2022-02-18","current":-2.09909,"twenty":-31.029239,"median":-10.947584,"eighty":-3.353464,"marketCap":142551331},{"date":"2022-02-25","current":-2.034002,"twenty":-31.012381,"median":-10.919045,"eighty":-3.299185,"marketCap":138131135},{"date":"2022-03-04","current":-1.901853,"twenty":-30.903906,"median":-10.889639,"eighty":-3.262715,"marketCap":131967682},{"date":"2022-03-11","current":-1.961785,"twenty":-30.564854,"median":-10.825686,"eighty":-3.217769,"marketCap":136126327},{"date":"2022-03-18","current":-2.045691,"twenty":-30.468636,"median":-10.808107,"eighty":-3.180314,"marketCap":141948431},{"date":"2022-03-25","current":-2.017722,"twenty":-30.27946,"median":-10.764934,"eighty":-3.171159,"marketCap":140007730},{"date":"2022-04-01","current":-1.981763,"twenty":-30.206073,"median":-10.690732,"eighty":-3.162158,"marketCap":137512542},{"date":"2022-04-08","current":-2.105623,"twenty":-30.113715,"median":-10.627946,"eighty":-3.149121,"marketCap":146107076},{"date":"2022-04-14","current":-2.00174,"twenty":-30.083493,"median":-10.593707,"eighty":-3.137866,"marketCap":138898758},{"date":"2022-04-22","current":-1.869889,"twenty":-30.015267,"median":-10.582284,"eighty":-3.117058,"marketCap":129749738},{"date":"2022-04-29","current":-1.663262,"twenty":-29.933561,"median":-10.576523,"eighty":-3.087926,"marketCap":115412119},{"date":"2022-05-06","current":-1.435368,"twenty":-29.852185,"median":-10.553745,"eighty":-3.075441,"marketCap":105439227},{"date":"2022-05-13","current":-1.337158,"twenty":-29.771616,"median":-10.490605,"eighty":-3.062957,"marketCap":98224964},{"date":"2022-05-20","current":-1.43159,"twenty":-29.770644,"median":-10.475071,"eighty":-3.029664,"marketCap":105161755},{"date":"2022-05-27","current":-1.507136,"twenty":-29.640178,"median":-10.456712,"eighty":-3.000532,"marketCap":110711188},{"date":"2022-06-03","current":-1.575127,"twenty":-29.577676,"median":-10.433881,"eighty":-2.930617,"marketCap":115705678},{"date":"2022-06-10","current":-1.790432,"twenty":-29.513656,"median":-10.370737,"eighty":-2.89233,"marketCap":131521562},{"date":"2022-06-17","current":-1.620454,"twenty":-29.488512,"median":-10.301585,"eighty":-2.863198,"marketCap":119035337},{"date":"2022-06-24","current":-1.756437,"twenty":-29.455895,"median":-10.251231,"eighty":-2.824912,"marketCap":129024317},{"date":"2022-07-01","current":-1.699777,"twenty":-29.392293,"median":-10.19986,"eighty":-2.630372,"marketCap":124862242},{"date":"2022-07-08","current":-1.816873,"twenty":-29.327482,"median":-10.133412,"eighty":-2.540062,"marketCap":133463863},{"date":"2022-07-15","current":-1.726218,"twenty":-29.267353,"median":-10.068581,"eighty":-2.52379,"marketCap":126804544},{"date":"2022-07-22","current":-1.703555,"twenty":-29.221057,"median":-9.983688,"eighty":-2.496128,"marketCap":125139714},{"date":"2022-07-29","current":-1.624232,"twenty":-29.079772,"median":-9.932137,"eighty":-2.464397,"marketCap":119312809},{"date":"2022-08-05","current":-1.780832,"twenty":-28.947368,"median":-9.846219,"eighty":-2.440803,"marketCap":130697055},{"date":"2022-08-12","current":-1.924509,"twenty":-28.936385,"median":-9.811852,"eighty":-2.418022,"marketCap":141241615},{"date":"2022-08-19","current":-1.803518,"twenty":-28.883293,"median":-9.748914,"eighty":-2.374901,"marketCap":132361985},{"date":"2022-08-26","current":-1.663622,"twenty":-28.776985,"median":-9.725934,"eighty":-2.364325,"marketCap":122094913},{"date":"2022-09-02","current":-1.538851,"twenty":-28.698739,"median":-9.559959,"eighty":-2.328526,"marketCap":112937795},{"date":"2022-09-09","current":-1.440546,"twenty":-28.685307,"median":-9.528322,"eighty":-2.312254,"marketCap":105723095},{"date":"2022-09-16","current":-1.463232,"twenty":-28.673616,"median":-9.497799,"eighty":-2.295169,"marketCap":107388026},{"date":"2022-09-23","current":-1.122945,"twenty":-28.646583,"median":-9.444387,"eighty":-2.230894,"marketCap":82414066},{"date":"2022-09-30","current":-1.039764,"twenty":-28.558519,"median":-9.383643,"eighty":-2.193469,"marketCap":76309321},{"date":"2022-10-07","current":-1.145631,"twenty":-28.537743,"median":-9.377244,"eighty":-2.176383,"marketCap":84078997},{"date":"2022-10-14","current":-1.020859,"twenty":-28.513281,"median":-9.350036,"eighty":-2.135702,"marketCap":74921878},{"date":"2022-10-21","current":-0.903649,"twenty":-28.42673,"median":-9.335006,"eighty":-2.100397,"marketCap":66319737},{"date":"2022-10-28","current":-0.949021,"twenty":-28.352993,"median":-9.304935,"eighty":-2.086886,"marketCap":69649598},{"date":"2022-11-04","current":-0.739439,"twenty":-28.262004,"median":-9.197537,"eighty":-2.063915,"marketCap":54993581},{"date":"2022-11-11","current":-0.661014,"twenty":-28.116474,"median":-9.086124,"eighty":-2.04649,"marketCap":49160928},{"date":"2022-11-18","current":-0.556447,"twenty":-28.052158,"median":-9.067704,"eighty":-2.034742,"marketCap":41384058},{"date":"2022-11-25","current":-0.541509,"twenty":-28.027666,"median":-9.029996,"eighty":-2.025866,"marketCap":40273077},{"date":"2022-12-02","current":-0.52657,"twenty":-27.675038,"median":-8.973018,"eighty":-2.009731,"marketCap":39162095},{"date":"2022-12-09","current":-0.504163,"twenty":-27.605334,"median":-8.926895,"eighty":-1.993322,"marketCap":37495623},{"date":"2022-12-16","current":-0.474287,"twenty":-27.600864,"median":-8.882534,"eighty":-1.977767,"marketCap":35273660},{"date":"2022-12-23","current":-0.459349,"twenty":-27.565163,"median":-8.802314,"eighty":-1.962318,"marketCap":34162679},{"date":"2022-12-30","current":-0.52657,"twenty":-27.529121,"median":-8.737875,"eighty":-1.958582,"marketCap":39162095},{"date":"2023-01-06","current":-0.604996,"twenty":-27.456005,"median":-8.69062,"eighty":-1.937028,"marketCap":44994748},{"date":"2023-01-13","current":-0.601261,"twenty":-27.359955,"median":-8.626181,"eighty":-1.90966,"marketCap":44717002},{"date":"2023-01-20","current":-0.646076,"twenty":-27.246132,"median":-8.574631,"eighty":-1.905849,"marketCap":48049947},{"date":"2023-01-27","current":-0.623669,"twenty":-26.955846,"median":-8.480121,"eighty":-1.890112,"marketCap":46383475},{"date":"2023-02-03","current":-0.619934,"twenty":-26.621528,"median":-8.294387,"eighty":-1.855725,"marketCap":46105729},{"date":"2023-02-10","current":-0.634872,"twenty":-26.482469,"median":-7.977692,"eighty":-1.830429,"marketCap":47216711},{"date":"2023-02-17","current":-0.590058,"twenty":-26.415476,"median":-7.645917,"eighty":-1.805709,"marketCap":43883766},{"date":"2023-02-24","current":-0.593792,"twenty":-26.370562,"median":-7.547892,"eighty":-1.802115,"marketCap":44161512},{"date":"2023-03-03","current":-0.557475,"twenty":-26.343023,"median":-7.461178,"eighty":-1.784389,"marketCap":41661804},{"date":"2023-03-10","current":-0.553759,"twenty":-26.293765,"median":-7.344302,"eighty":-1.767869,"marketCap":41384058},{"date":"2023-03-17","current":-0.59464,"twenty":-26.246562,"median":-7.208576,"eighty":-1.729995,"marketCap":44439257},{"date":"2023-03-24","current":-0.579774,"twenty":-26.136983,"median":-7.118092,"eighty":-1.711864,"marketCap":43328276},{"date":"2023-03-31","current":-0.550042,"twenty":-26.104953,"median":-7.050229,"eighty":-1.703887,"marketCap":41106313},{"date":"2023-04-06","current":-0.546326,"twenty":-26.003804,"median":-6.933353,"eighty":-1.701432,"marketCap":40828567},{"date":"2023-04-14","current":-0.5742,"twenty":-25.708785,"median":-6.831559,"eighty":-1.688445,"marketCap":42911658},{"date":"2023-04-21","current":-0.576058,"twenty":-25.430624,"median":-6.685709,"eighty":-1.663262,"marketCap":43050530},{"date":"2023-04-28","current":-0.561192,"twenty":-25.396908,"median":-6.034448,"eighty":-1.639341,"marketCap":41939549},{"date":"2023-05-05","current":-0.591934,"twenty":-25.144034,"median":-3.755599,"eighty":-1.624232,"marketCap":44237008},{"date":"2023-05-12","current":-0.705187,"twenty":-25.135605,"median":-3.667028,"eighty":-1.620454,"marketCap":49523192},{"date":"2023-05-19","current":-0.704642,"twenty":-25.08503,"median":-3.66044,"eighty":-1.620454,"marketCap":49484904},{"date":"2023-05-22","current":-0.713441,"twenty":-25.034456,"median":-3.653853,"eighty":-1.616864,"marketCap":50102839},{"date":"2023-06-09","current":-0.701551,"twenty":-24.933307,"median":-3.649461,"eighty":-1.591082,"marketCap":49267792},{"date":"2023-06-15","current":-0.642097,"twenty":-24.710778,"median":-3.636286,"eighty":-1.5824,"marketCap":45092555},{"date":"2023-06-30","current":-0.713441,"twenty":-24.538824,"median":-3.634692,"eighty":-1.577253,"marketCap":50102839},{"date":"2023-07-07","current":-0.709478,"twenty":-23.845136,"median":-3.624776,"eighty":-1.54112,"marketCap":49824490},{"date":"2023-07-21","current":-0.709478,"twenty":-23.117786,"median":-3.614328,"eighty":-1.50226,"marketCap":49824490},{"date":"2023-07-28","current":-0.681733,"twenty":-23.046872,"median":-3.602675,"eighty":-1.463703,"marketCap":47876046},{"date":"2023-08-04","current":-0.681733,"twenty":-23.006412,"median":-3.59237,"eighty":-1.440546,"marketCap":47876046},{"date":"2023-08-11","current":-0.686417,"twenty":-22.947409,"median":-3.589846,"eighty":-1.432346,"marketCap":48163144},{"date":"2023-08-18","current":-0.642772,"twenty":-22.917064,"median":-3.574803,"eighty":-1.372977,"marketCap":45100748},{"date":"2023-08-25","current":-0.61103,"twenty":-22.873232,"median":-3.566382,"eighty":-1.367642,"marketCap":42873550},{"date":"2023-09-01","current":-0.579288,"twenty":-22.836144,"median":-3.53967,"eighty":-1.334136,"marketCap":40646353},{"date":"2023-09-08","current":-0.575321,"twenty":-22.741738,"median":-3.530886,"eighty":-1.280499,"marketCap":40367953},{"date":"2023-09-15","current":-0.547547,"twenty":-22.669256,"median":-3.524299,"eighty":-1.145631,"marketCap":38419155},{"date":"2023-09-22","current":-0.531676,"twenty":-22.63216,"median":-3.517711,"eighty":-1.111602,"marketCap":37305557},{"date":"2023-09-29","current":-0.511837,"twenty":-22.606872,"median":-3.511124,"eighty":-1.06245,"marketCap":35913558},{"date":"2023-10-06","current":-0.499934,"twenty":-22.573156,"median":-3.495753,"eighty":-1.039764,"marketCap":35078359},{"date":"2023-10-13","current":-0.491998,"twenty":-22.514152,"median":-3.489166,"eighty":-1.017078,"marketCap":34521560},{"date":"2023-10-20","current":-0.519773,"twenty":-22.505723,"median":-3.473795,"eighty":-0.956583,"marketCap":36470358},{"date":"2023-10-27","current":-0.412644,"twenty":-22.45852,"median":-3.473795,"eighty":-0.946752,"marketCap":28953566},{"date":"2023-11-03","current":-0.464224,"twenty":-22.343884,"median":-3.458424,"eighty":-0.937493,"marketCap":32572762},{"date":"2023-11-10","current":-0.455431,"twenty":-22.193846,"median":-3.449988,"eighty":-0.733353,"marketCap":29856238},{"date":"2023-11-17","current":-0.497995,"twenty":-22.043808,"median":-3.444555,"eighty":-0.713441,"marketCap":32646541},{"date":"2023-11-24","current":-0.536302,"twenty":-21.990775,"median":-3.420975,"eighty":-0.709478,"marketCap":35157814},{"date":"2023-12-01","current":-0.502251,"twenty":-21.915966,"median":-3.412312,"eighty":-0.704751,"marketCap":32925571},{"date":"2023-12-08","current":-0.532046,"twenty":-21.898827,"median":-3.379374,"eighty":-0.697587,"marketCap":34878783},{"date":"2023-12-15","current":-0.497995,"twenty":-21.888712,"median":-3.327628,"eighty":-0.693366,"marketCap":32646541},{"date":"2023-12-22","current":-0.476713,"twenty":-21.839823,"median":-3.284954,"eighty":-0.68402,"marketCap":31251390},{"date":"2023-12-29","current":-0.489482,"twenty":-21.814536,"median":-3.2752,"eighty":-0.681733,"marketCap":32088481},{"date":"2024-01-05","current":-0.510764,"twenty":-21.779134,"median":-3.262715,"eighty":-0.679782,"marketCap":33483632},{"date":"2024-01-12","current":-0.497995,"twenty":-21.725188,"median":-3.241038,"eighty":-0.674514,"marketCap":32646541},{"date":"2024-01-19","current":-0.489482,"twenty":-21.681649,"median":-3.216937,"eighty":-0.673806,"marketCap":32088481},{"date":"2024-01-26","current":-0.506507,"twenty":-21.57632,"median":-3.183644,"eighty":-0.658026,"marketCap":33204602},{"date":"2024-02-02","current":-0.553327,"twenty":-21.441436,"median":-3.179482,"eighty":-0.643433,"marketCap":36273935},{"date":"2024-02-09","current":-0.553327,"twenty":-21.090872,"median":-3.171159,"eighty":-0.639246,"marketCap":36273935},{"date":"2024-02-16","current":-0.600147,"twenty":-21.055916,"median":-3.170771,"eighty":-0.634872,"marketCap":39343268},{"date":"2024-02-23","current":-0.646967,"twenty":-20.988483,"median":-3.161988,"eighty":-0.634872,"marketCap":42412601},{"date":"2024-03-01","current":-0.736351,"twenty":-20.905775,"median":-3.156169,"eighty":-0.634872,"marketCap":48272236},{"date":"2024-03-08","current":-0.7023,"twenty":-20.829927,"median":-3.146189,"eighty":-0.634872,"marketCap":46039994},{"date":"2024-03-15","current":-0.625686,"twenty":-20.53714,"median":-3.136752,"eighty":-0.634872,"marketCap":41017449},{"date":"2024-03-22","current":-0.747367,"twenty":-20.432162,"median":-3.118071,"eighty":-0.631138,"marketCap":46877085},{"date":"2024-03-28","current":-0.860806,"twenty":-20.43181,"median":-3.100505,"eighty":-0.631672,"marketCap":53992357},{"date":"2024-04-05","current":-0.9609,"twenty":-20.149891,"median":-3.087926,"eighty":-0.634259,"marketCap":60270538},{"date":"2024-04-12","current":-0.836339,"twenty":-19.944111,"median":-3.078546,"eighty":-0.634872,"marketCap":52457690},{"date":"2024-04-19","current":-0.700191,"twenty":-19.91028,"median":-3.074798,"eighty":-0.634872,"marketCap":43918063},{"date":"2024-04-26","current":-0.575316,"twenty":-19.842002,"median":-3.07128,"eighty":-0.634872,"marketCap":36085542},{"date":"2024-05-03","current":-0.664512,"twenty":-19.805649,"median":-3.045609,"eighty":-0.631672,"marketCap":41680200},{"date":"2024-05-10","current":-0.75492,"twenty":-19.788888,"median":-3.029664,"eighty":-0.633645,"marketCap":48114057},{"date":"2024-05-17","current":-0.724196,"twenty":-19.653566,"median":-2.983885,"eighty":-0.633645,"marketCap":46155926},{"date":"2024-05-24","current":-0.70664,"twenty":-18.732713,"median":-2.902734,"eighty":-0.633645,"marketCap":45036995},{"date":"2024-05-31","current":-0.693473,"twenty":-18.26814,"median":-2.86736,"eighty":-0.633645,"marketCap":44197796},{"date":"2024-06-07","current":-0.539855,"twenty":-18.148679,"median":-2.761182,"eighty":-0.627403,"marketCap":34407145},{"date":"2024-06-14","current":-0.702251,"twenty":-18.173329,"median":-2.562843,"eighty":-0.627403,"marketCap":44757262},{"date":"2024-06-21","current":-0.65836,"twenty":-18.19798,"median":-2.526231,"eighty":-0.627403,"marketCap":41959933},{"date":"2024-06-28","current":-0.719807,"twenty":-18.26814,"median":-2.514027,"eighty":-0.627343,"marketCap":45876193},{"date":"2024-07-05","current":-0.689084,"twenty":-18.26814,"median":-2.489619,"eighty":-0.627343,"marketCap":43918063},{"date":"2024-07-12","current":-0.700056,"twenty":-18.26814,"median":-2.440803,"eighty":-0.627343,"marketCap":44617395},{"date":"2024-07-15","current":-0.724196,"twenty":-18.26814,"median":-2.440803,"eighty":-0.627343,"marketCap":46155926},{"date":"2024-08-02","current":-0.70664,"twenty":-14.460919,"median":-2.375715,"eighty":-0.625686,"marketCap":45036995},{"date":"2024-08-09","current":-0.71219,"twenty":-14.245084,"median":-2.353341,"eighty":-0.625686,"marketCap":43642310},{"date":"2024-08-16","current":-0.71219,"twenty":-13.890499,"median":-2.320797,"eighty":-0.625686,"marketCap":43642310},{"date":"2024-08-23","current":-0.721321,"twenty":-13.207877,"median":-2.296389,"eighty":-0.625686,"marketCap":44201827},{"date":"2024-08-30","current":-0.716756,"twenty":-13.002396,"median":-2.223165,"eighty":-0.625686,"marketCap":43922068},{"date":"2024-09-06","current":-0.657406,"twenty":-12.819746,"median":-2.186553,"eighty":-0.625686,"marketCap":40285209},{"date":"2024-09-13","current":-0.630015,"twenty":-11.925438,"median":-2.170281,"eighty":-0.623669,"marketCap":38606659},{"date":"2024-09-20","current":-0.652841,"twenty":-11.769509,"median":-2.105623,"eighty":-0.623669,"marketCap":40005451},{"date":"2024-09-27","current":-0.64371,"twenty":-11.598274,"median":-2.086886,"eighty":-0.623669,"marketCap":39445934},{"date":"2024-10-04","current":-0.598057,"twenty":-11.461287,"median":-2.062478,"eighty":-0.621429,"marketCap":36648350},{"date":"2024-10-11","current":-0.630015,"twenty":-11.143583,"median":-2.043693,"eighty":-0.618966,"marketCap":38606659},{"date":"2024-10-18","current":-0.661972,"twenty":-10.913337,"median":-2.027788,"eighty":-0.618966,"marketCap":40564968},{"date":"2024-10-25","current":-0.616319,"twenty":-10.822012,"median":-2.005736,"eighty":-0.617173,"marketCap":37767384},{"date":"2024-10-31","current":-0.616319,"twenty":-10.764934,"median":-1.98954,"eighty":-0.617173,"marketCap":37767384},{"date":"2024-11-08","current":-0.602623,"twenty":-10.621175,"median":-1.977767,"eighty":-0.616319,"marketCap":36928108},{"date":"2024-11-15","current":-0.640617,"twenty":-10.582284,"median":-1.960778,"eighty":-0.616319,"marketCap":37487625},{"date":"2024-11-22","current":-0.617393,"twenty":-10.508965,"median":-1.933817,"eighty":-0.616319,"marketCap":36128622},{"date":"2024-11-29","current":-0.559961,"twenty":-10.470905,"median":-1.905849,"eighty":-0.612684,"marketCap":32767820},{"date":"2024-12-06","current":-0.521673,"twenty":-10.415615,"median":-1.89048,"eighty":-0.609811,"marketCap":30527285},{"date":"2024-12-13","current":-0.521673,"twenty":-10.270434,"median":-1.848889,"eighty":-0.607188,"marketCap":30527285},{"date":"2024-12-20","current":-0.454669,"twenty":-10.143923,"median":-1.824428,"eighty":-0.604996,"marketCap":26606349},{"date":"2024-12-27","current":-0.396185,"twenty":-10.050315,"median":-1.805541,"eighty":-0.602075,"marketCap":23183933},{"date":"2025-01-03","current":-0.393409,"twenty":-9.932137,"median":-1.794209,"eighty":-0.601294,"marketCap":23021494},{"date":"2025-01-10","current":-0.407288,"twenty":-9.818652,"median":-1.777211,"eighty":-0.600815,"marketCap":23833688},{"date":"2025-01-17","current":-0.366607,"twenty":-9.72937,"median":-1.735661,"eighty":-0.598057,"marketCap":21453119},{"date":"2025-01-24","current":-0.410638,"twenty":-9.543598,"median":-1.712997,"eighty":-0.59464,"marketCap":24029734},{"date":"2025-01-31","current":-0.382401,"twenty":-9.475453,"median":-1.703555,"eighty":-0.59153,"marketCap":22377340},{"date":"2025-02-07","current":-0.378094,"twenty":-9.382261,"median":-1.696,"eighty":-0.587316,"marketCap":22125280},{"date":"2025-02-14","current":-0.346793,"twenty":-9.348751,"median":-1.663442,"eighty":-0.58313,"marketCap":20293643},{"date":"2025-02-21","current":-0.359428,"twenty":-9.263694,"median":-1.646895,"eighty":-0.580377,"marketCap":21033019},{"date":"2025-02-28","current":-0.368043,"twenty":-9.078223,"median":-1.623756,"eighty":-0.579114,"marketCap":21537139},{"date":"2025-03-07","current":-0.341194,"twenty":-8.986591,"median":-1.61447,"eighty":-0.575321,"marketCap":19965965},{"date":"2025-03-14","current":-0.362325,"twenty":-8.893686,"median":-1.569098,"eighty":-0.574813,"marketCap":20164812},{"date":"2025-03-21","current":-0.309184,"twenty":-8.741312,"median":-1.507136,"eighty":-0.570766,"marketCap":17207306},{"date":"2025-03-28","current":-0.267063,"twenty":-8.611093,"median":-1.463232,"eighty":-0.568625,"marketCap":14863147},{"date":"2025-04-04","current":-0.199782,"twenty":-8.476684,"median":-1.440546,"eighty":-0.565874,"marketCap":11118653},{"date":"2025-04-11","current":-0.135872,"twenty":-7.959595,"median":-1.420259,"eighty":-0.561581,"marketCap":7561804},{"date":"2025-04-17","current":-0.168481,"twenty":-7.569005,"median":-1.371154,"eighty":-0.560181,"marketCap":9376637},{"date":"2025-04-25","current":-0.210853,"twenty":-7.344302,"median":-1.337158,"eighty":-0.559654,"marketCap":11734800},{"date":"2025-05-02","current":-0.24155,"twenty":-7.11206,"median":-1.276722,"eighty":-0.557475,"marketCap":13443208},{"date":"2025-05-09","current":-0.217729,"twenty":-6.877785,"median":-1.134288,"eighty":-0.555287,"marketCap":10782573},{"date":"2025-05-16","current":-0.23336,"twenty":-6.545868,"median":-1.070012,"eighty":-0.553759,"marketCap":11556678},{"date":"2025-05-23","current":-0.281561,"twenty":-3.703039,"median":-1.051107,"eighty":-0.550181,"marketCap":13943749},{"date":"2025-05-30","current":-0.281165,"twenty":-3.644191,"median":-1.027629,"eighty":-0.549404,"marketCap":13924114},{"date":"2025-06-06","current":-0.280655,"twenty":-3.614328,"median":-0.99204,"eighty":-0.545892,"marketCap":13898869},{"date":"2025-06-13","current":-0.368335,"twenty":-3.59237,"median":-0.956583,"eighty":-0.542337,"marketCap":18241039},{"date":"2025-06-20","current":-0.256356,"twenty":-3.57483,"median":-0.939569,"eighty":-0.54061,"marketCap":12695516},{"date":"2025-06-27","current":-0.260547,"twenty":-3.545774,"median":-0.894462,"eighty":-0.536302,"marketCap":12903087},{"date":"2025-07-03","current":-0.24684,"twenty":-3.530008,"median":-0.849684,"eighty":-0.53175,"marketCap":12224273},{"date":"2025-07-11","current":-0.265192,"twenty":-3.51332,"median":-0.810837,"eighty":-0.528292,"marketCap":13133099},{"date":"2025-07-18","current":-0.242139,"twenty":-3.491362,"median":-0.74804,"eighty":-0.526798,"marketCap":11991446},{"date":"2025-07-25","current":-0.248275,"twenty":-3.472038,"median":-0.736291,"eighty":-0.52374,"marketCap":12295323},{"date":"2025-08-01","current":-0.268031,"twenty":-3.449479,"median":-0.731713,"eighty":-0.523533,"marketCap":13273713},{"date":"2025-08-08","current":-0.275326,"twenty":-3.419147,"median":-0.729434,"eighty":-0.521673,"marketCap":13634994},{"date":"2025-08-15","current":-0.226104,"twenty":-3.369274,"median":-0.724196,"eighty":-0.519376,"marketCap":13775811},{"date":"2025-08-22","current":-0.224448,"twenty":-3.275977,"median":-0.720564,"eighty":-0.512543,"marketCap":13674922},{"date":"2025-08-29","current":-0.225326,"twenty":-3.23705,"median":-0.71609,"eighty":-0.510764,"marketCap":13728444},{"date":"2025-09-05","current":-0.216981,"twenty":-3.183644,"median":-0.713441,"eighty":-0.507869,"marketCap":13219983},{"date":"2025-09-12","current":-0.238942,"twenty":-3.171159,"median":-0.710254,"eighty":-0.502633,"marketCap":14558038},{"date":"2025-09-19","current":-0.248456,"twenty":-3.161988,"median":-0.708059,"eighty":-0.500566,"marketCap":15137683},{"date":"2025-09-26","current":-0.253876,"twenty":-3.144524,"median":-0.703851,"eighty":-0.497995,"marketCap":15467915},{"date":"2025-10-03","current":-0.252699,"twenty":-3.117868,"median":-0.702251,"eighty":-0.496147,"marketCap":15396196},{"date":"2025-10-10","current":-0.286819,"twenty":-3.087926,"median":-0.700124,"eighty":-0.489482,"marketCap":17474998},{"date":"2025-10-16","current":-0.299117,"twenty":-3.075184,"median":-0.697724,"eighty":-0.489482,"marketCap":18224309}],"updateTime":1760766493798},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NXTC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2575264728","title":"NextCure Inc. Releases Corporate Presentation Highlighting Progress of Targeted Cancer Therapies and Ongoing Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2575264728","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575264728?lang=en_us&edition=fundamental","pubTime":"2025-10-16 23:12","pubTimestamp":1760627533,"startTime":"0","endTime":"0","summary":"NextCure Inc. provided an update on its ongoing clinical programs in its latest corporate presentation. The company reported progress on two differentiated antibody-drug conjugate  programs that are currently in Phase 1 trials. These programs, LNCB74 targeting CDH6 with a TOPO payload and another targeting B7-H4 with an MMAE payload, are being developed in collaboration with Simcere Zaiming. NextCure anticipates proof-of-concept  data for both ADCs in the first half of 2026. The presentation also provided an overview of research and development milestones and outlined the company's ongoing efforts in the development of targeted therapies for cancer. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investme","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL81CSG1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"gpt_icon":0},{"id":"2575074517","title":"BRIEF-NextCure And Simcere Zaiming Announce Expansion Of Ongoing Phase 1 Trial Of SIM0505 Into The US","url":"https://stock-news.laohu8.com/highlight/detail?id=2575074517","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575074517?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:06","pubTimestamp":1760616405,"startTime":"0","endTime":"0","summary":"BRIEF-NextCure And Simcere Zaiming Announce Expansion Of Ongoing Phase 1 Trial Of SIM0505 Into The USOct 16 (Reuters) - NextCure Inc NXTC.O:NEXTCURE AND SIMCERE ZAIMING ANNOUNCE EXPANSION OF ONGOING P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA6ZQ3RM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","02096","BK1191","BK1583","NXTC"],"gpt_icon":0},{"id":"2575174518","title":"NextCure and Simcere Zaiming Expand Phase 1 Trial of SIM0505 (CDH6 ADC) into U.S.; First American Patient Dosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2575174518","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575174518?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:05","pubTimestamp":1760616316,"startTime":"0","endTime":"0","summary":"NextCure Inc. and Simcere Zaiming have announced the expansion of the ongoing Phase 1 clinical trial of SIM0505, a novel antibody drug conjugate targeting cadherin-6 , into the United States. The first U.S. patient has been dosed at a mid-tier dose level where multiple responses have previously been observed. The multi-regional trial, which began in China, is evaluating safety, tolerability, pharmacokinetics, and efficacy in patients with advanced solid tumors. NextCure expects to present proof-of-concept clinical data in the first half of 2026. No clinical results have been presented yet.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief via GlobeNewswire  on O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL51tgV4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2210149790.SGD","LU2210150020.SGD","NDAQ","BK4588","BK4139","LU0314104364.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4585","BK4112","IE00B64PRP62.GBP","NXTC","LU2095319765.USD"],"gpt_icon":0},{"id":"2575459727","title":"NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of Sim0505 (Cdh6 ADC) Into the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2575459727","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575459727?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:05","pubTimestamp":1760616300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA6ZQ3RM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","02096","BK4139","BK1191","NXTC"],"gpt_icon":0},{"id":"2575074590","title":"NextCure Inc - Trial to Accelerate Proof-of-Concept Data in 1H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2575074590","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575074590?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:05","pubTimestamp":1760616300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA6ZQ3RM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","NXTC","BK1583","BK4139","02096"],"gpt_icon":0},{"id":"2564844522","title":"NextCure Inc. Unveils Latest Developments in Cancer Therapy Targeting and Clinical Trials Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2564844522","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564844522?lang=en_us&edition=fundamental","pubTime":"2025-09-02 03:10","pubTimestamp":1756753826,"startTime":"0","endTime":"0","summary":"NextCure Inc. has released a corporate presentation outlining their current and future initiatives in the field of targeted cancer therapy. The document details ongoing Phase 1 clinical trials involving two differentiated antibody-drug conjugates . Additionally, the presentation highlights the company's co-development efforts with Simcere, targeting proteins B7-H4 and CDH6, with payloads MMAE and TOPOi, respectively. Preclinical and Phase 1 milestones are anticipated, with proof-of-concept data expected in the first half of 2026. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief on September 01, 2025, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nNDLbrwxT3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"gpt_icon":0},{"id":"2562277812","title":"NextCure Inc. Announces Resignation of Chief Scientific Officer Solomon Langermann, Effective September 1, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2562277812","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562277812?lang=en_us&edition=fundamental","pubTime":"2025-08-26 04:11","pubTimestamp":1756152709,"startTime":"0","endTime":"0","summary":"NextCure Inc. announced that Solomon Langermann, Ph.D., has resigned from his position as Chief Scientific Officer, effective September 1, 2025. The company confirmed that his resignation was not due to any disagreements related to company operations or policies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 25, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nNDLbLTTLV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"gpt_icon":0},{"id":"2560104144","title":"NextCure Inc. Files Initial Statement of Beneficial Ownership for Simcere Zaiming, Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2560104144","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560104144?lang=en_us&edition=fundamental","pubTime":"2025-08-20 09:33","pubTimestamp":1755653581,"startTime":"0","endTime":"0","summary":"NextCure Inc. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing mentions Simcere Zaiming, Inc. as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL3RwYL0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"gpt_icon":0},{"id":"2557251495","title":"NextCure Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2557251495","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557251495?lang=en_us&edition=fundamental","pubTime":"2025-08-08 12:17","pubTimestamp":1754626621,"startTime":"0","endTime":"0","summary":"NextCure Inc reports results for the quarter ended June 30 - Earnings SummaryNextCure Inc NXTC.OQ reported a quarterly adjusted loss of $11.29 per share for the quarter ended June 30, lower than the s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U00MN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC"],"gpt_icon":0},{"id":"2557591599","title":"NextCure Q2 EPS $(11.29) Misses $(0.39) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557591599","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557591599?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:58","pubTimestamp":1754600298,"startTime":"0","endTime":"0","summary":"NextCure (NASDAQ:NXTC) reported quarterly losses of $(11.29) per share which missed the analyst consensus estimate of $(0.39) by 2832.47 percent. This is a 70.8 percent decrease over losses of $(6.61) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46982522/nextcure-q2-eps-11-29-misses-0-39-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"NextCure Q2 EPS $(11.29) Misses $(0.39) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC"],"gpt_icon":0},{"id":"2557599829","title":"NextCure Inc. Unveils Corporate Presentation Highlighting Licensing Agreement with Simcere and Progress in ADC Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2557599829","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557599829?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:19","pubTimestamp":1754597973,"startTime":"0","endTime":"0","summary":"NextCure Inc. Unveils Corporate Presentation Highlighting Licensing Agreement with Simcere and Progress in ADC Clinical Trials. NextCure Inc. presented an update on their ongoing programs, highlighting the development of two differentiated Antibody-Drug Conjugates  currently in Phase 1 clinical trials. The ADCs target B7-H4 and CDH6, with MMAE and Topoisomerase 1 inhibitors as payloads, respectively. The company aims to collect Proof of Concept  data by the first half of 2026. NextCure's approach focuses on tumor eradication, overcoming resistance, and increasing durability in cancer treatments with limited options. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nNDL8hzmYp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"gpt_icon":0},{"id":"2554775308","title":"NextCure Inc  expected to post a loss of $4.61 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2554775308","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554775308?lang=en_us&edition=fundamental","pubTime":"2025-07-28 19:02","pubTimestamp":1753700533,"startTime":"0","endTime":"0","summary":"NextCure Inc  expected to post a loss of $4.61 a share - Earnings Preview NextCure Inc NXTC.OQ NXTC.O is expected to  show no change in quarterly revenue when it reports  results on July 30 (estimated","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nL8N3TP0OY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC"],"gpt_icon":0},{"id":"2554879957","title":"NextCure Shares Surge on Positive Data for Bone Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2554879957","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554879957?lang=en_us&edition=fundamental","pubTime":"2025-07-26 00:14","pubTimestamp":1753460040,"startTime":"0","endTime":"0","summary":"Shares of NextCure rose after the company said preclinical data supported its treatment of osteogenesis imperfecta, commonly called brittle bone disease.The stock was up 16% to $6.09 on Friday. It is down 34% so far this year.The Beltsville, Md.-based biopharmaceutical company said preclinical data showed its NC605 antibody treatment achieved improved bone microarchitecture and reduced fractures compared to anti-sclerostin treatment, another treatment for brittle bone disease.The company said it is looking for financial support to advance NC605 to an investigational new drug submission with the FDA within 12 to 18 months.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"NextCure Shares Surge on Positive Data for Bone Treatment","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"gpt_icon":0},{"id":"2554738528","title":"NextCure Inc. Announces Promising Preclinical Results for Anti-Siglec-15 Treatment NC605 in Osteogenesis Imperfecta Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2554738528","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554738528?lang=en_us&edition=fundamental","pubTime":"2025-07-25 04:05","pubTimestamp":1753387536,"startTime":"0","endTime":"0","summary":"NextCure Inc., a clinical-stage biopharmaceutical company, has announced preclinical data demonstrating the effectiveness of NC605, a novel anti-Siglec-15 antibody, in treating osteogenesis imperfecta  in a well-established mouse model. The study results showed that NC605 improved bone microarchitecture and reduced fracture incidence compared to anti-sclerostin treatment. These findings were presented at the Brittle Bone Society Meeting on July 24, 2025. Currently, there is no FDA-approved standard of care for OI, and NC605 could offer significant therapeutic benefits for patients suffering from this rare disorder, characterized by high bone turnover and fragility. NextCure is actively seeking financial partners to advance NC605 towards an Investigational New Drug submission within 12 to 18 months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated cont","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nNDLsCY0L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4585","NXTC","IE00BGHQF748.EUR","BK4112","NDAQ","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU2210150020.SGD","LU2095319765.USD","BK4139","BK4588"],"gpt_icon":0},{"id":"2551154548","title":"U.S. RESEARCH ROUNDUP-Nvidia, Strategy, Targa Resources","url":"https://stock-news.laohu8.com/highlight/detail?id=2551154548","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551154548?lang=en_us&edition=fundamental","pubTime":"2025-07-15 15:52","pubTimestamp":1752565945,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Nvidia, Strategy, Targa ResourcesJuly 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Nvidia, S","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b2d00f04917709ec6fbd34efb37ac691","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nL4N3TC0LI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BMG7P702.HKD","RES","TRGP","XPRO","MSTR","HK0000306685.HKD","NVDS","LU2125154935.USD","NVD3.UK","RNGR","LU0157215616.USD","D","FAST","NVD","NESR","DINO","IE00BWXC8680.SGD","IE0009356076.USD","NVD2.UK","ENTG","NXTC","LU0957808578.USD","TMDX","NVDD","2NVD.UK","COP","LU0472753341.HKD","LU2420271590.USD","NVDS.UK","INVX","CPB","AMP","AMRZ","LU1668664300.SGD","AESI","NVDY","STRK","MPWR","NVDU","WTTR","3NVD.UK","IE00B19Z4B17.USD","NVIW.SI","NVDX","NVDA","SNVD.UK","EQH"],"gpt_icon":1},{"id":"2551188439","title":"NextCure Inc. Announces 1:12 Reverse Stock Split in Bylaw Amendment","url":"https://stock-news.laohu8.com/highlight/detail?id=2551188439","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551188439?lang=en_us&edition=fundamental","pubTime":"2025-07-14 19:16","pubTimestamp":1752491778,"startTime":"0","endTime":"0","summary":"NextCure Inc. has announced a one-for-twelve reverse stock split of its common stock, effective July 14, 2025. The stockholders approved an amendment enabling a reverse stock split at a ratio between one-to-five and one-to-fifteen, with the board of directors deciding on the final ratio. No fractional shares will be issued; instead, stockholders will receive cash for any fractional shares based on the closing price before the split. The common stock will trade on a split-adjusted basis on the Nasdaq Global Select Market under the ticker symbol \"NXTC\".Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nNDL7V8LQN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"gpt_icon":0},{"id":"2550623372","title":"NextCure Inc. Announces 1-for-12 Reverse Stock Split Effective July 14, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2550623372","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550623372?lang=en_us&edition=fundamental","pubTime":"2025-07-10 21:02","pubTimestamp":1752152521,"startTime":"0","endTime":"0","summary":"NextCure Inc., a Delaware corporation, announced a one-for-twelve reverse stock split of its common stock, set to take effect on July 14, 2025. This means every 12 shares of the company's common stock will be consolidated into one share. The stock will begin trading on a split-adjusted basis at market open on the effective date. Proportionate adjustments will be made to the company's equity awards and incentive plans.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 10, 2025, and is solely responsible for the information con","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250710:nNDL4jF68T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"gpt_icon":0},{"id":"2549536254","title":"NextCure Inc. Unveils Presentation on Licensing Agreement with Simcere Zaiming and Development Plans for Novel Therapeutic Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2549536254","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549536254?lang=en_us&edition=fundamental","pubTime":"2025-07-07 18:54","pubTimestamp":1751885650,"startTime":"0","endTime":"0","summary":"NextCure Inc. Unveils Presentation on Licensing Agreement with Simcere Zaiming and Development Plans for Novel Therapeutic Candidates. NextCure Inc. has released a corporate presentation detailing recent developments and future plans. The presentation highlights NextCure's ongoing collaboration with Simcere Zaiming, focusing on the global rights  for SIMOSOS , with Phase 1 trials initiated in China and FDA IND clearance obtained. Additionally, NextCure plans to leverage its existing infrastructure to commence a U.S. trial in the third quarter of 2025, aiming to combine data from China and the U.S. for a swift and conclusive proof of concept. The company anticipates Phase 1 readouts for LNCB74 and SIMOSOS in the first half of 2026. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nNDL5MZhQL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"gpt_icon":0},{"id":"2548003310","title":"NextCure Price Target Maintained With a $3.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2548003310","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548003310?lang=en_us&edition=fundamental","pubTime":"2025-07-01 18:59","pubTimestamp":1751367540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NXTC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 01, 2025 06:59 ET (10:59 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC"],"gpt_icon":0},{"id":"2545412193","title":"NextCure Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2545412193","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545412193?lang=en_us&edition=fundamental","pubTime":"2025-06-23 21:16","pubTimestamp":1750684582,"startTime":"0","endTime":"0","summary":"NextCure Inc. held its 2025 Annual Meeting of Stockholders on June 20, 2025. During the meeting, stockholders elected three Class III members to the Board of Directors. The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. An amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split, if determined by the Board, was approved. A proposal regarding adjournment of the Annual Meeting was rendered moot and was not presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nNDLLk4x3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}]}}